Theravance Biopharma Inc (TBPH)
EBITDA Growth
-98.88%
Quarterly · Period ending:
TBPH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-98.88%period ending
Latest reported-98.88%period ending
TBPH Quarterly EBITDA YoY % (-27.36% → -98.88%)
Year-over-year change
High-resolution chart · PNG
TBPH ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -98.8783% | |
| 54.7135% | |
| 1,088.7909% | |
| 80.2655% | |
| 735.2102% | |
| -44.7871% | |
| -46.7375% | |
| -51.0736% | |
| 16.0727% | |
| 61.5653% | |
| 55.6393% | |
| 52.7503% | |
| 22.857% | |
| 15.8639% | |
| 67.0197% | |
| 75.7774% | |
| 52.3364% | |
| 67.431% | |
| 53.0169% | |
| 17.9321% | |
| 22.4483% | |
| -15.5466% | |
| -33.5821% | |
| -11.1064% | |
| -62.8019% | |
| -12.1504% | |
| -16.2864% | |
| 5.827% | |
| 32.3605% | |
| -1.7171% | |
| 36.8148% | |
| 8.8775% | |
| 28.7612% | |
| -9.1509% | |
| -33.7543% | |
| -94.4529% | |
| -33.3248% | |
| -38.5243% | |
| -4.2232% | |
| 23.6366% | |
| -5.2463% | |
| -10.207% | |
| 15.2296% | |
| 13.4975% | |
| 20.2106% | |
| 37.336% | |
| -49.7534% | |
| -20.8929% | |
| -46.446% | |
| -88.383% | |
| -52.5527% | |
| -27.3564% |